GA
Geller Advisors Portfolio holdings
AUM
$1.52B
This Quarter Return
+7.19%
1 Year Return
+20.7%
3 Year Return
+20.44%
5 Year Return
+77.4%
10 Year Return
+246.37%
AUM
$591M
AUM Growth
+$591M
(+28%)
Cap. Flow
+$96.9M
Cap. Flow
% of AUM
16.4%
Top 10 Holdings %
Top 10 Hldgs %
87.15%
Holding
160
New
30
Increased
70
Reduced
39
Closed
12
Top Buys
| 1 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
$42.6M |
| 2 |
iShares Russell 1000 Value ETF
IWD
|
$21.7M |
| 3 |
iShares Russell 2000 ETF
IWM
|
$15.7M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
$11.4M |
| 5 |
iShares Russell 2000 Growth ETF
IWO
|
$7.26M |
Top Sells
| 1 |
iShares Russell 3000 ETF
IWV
|
$8.03M |
| 2 |
iShares S&P 100 ETF
OEF
|
$5.17M |
| 3 |
iShares MSCI KLD 400 Social ETF
DSI
|
$2.25M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
$770K |
| 5 |
AbbVie
ABBV
|
$542K |
Sector Composition
| 1 | Technology | 2.85% |
| 2 | Healthcare | 2.42% |
| 3 | Financials | 1.9% |
| 4 | Communication Services | 0.9% |
| 5 | Industrials | 0.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Mastercard
MA
$538B
| $1.11M | 0.19% |
3,189
-199
| -6% | -$69.2K |
|
27
PepsiCo
PEP
$204B
| $1.06M | 0.18% |
5,827
+157
| +3% | +$28.5K |
|
|
28
AbbVie
ABBV
$372B
| $989K | 0.17% |
6,122
-3,351
| -35% | -$542K |
|
29
Broadcom
AVGO
$1.4T
| $985K | 0.17% |
1,762
+10
| +0.6% | +$5.59K |
|
30
NVIDIA
NVDA
$4.24T
| $903K | 0.15% |
6,177
-92
| -1% | -$13.4K |
|
31
Idexx Laboratories
IDXX
$51.8B
| $893K | 0.15% |
2,188
-77
| -3% | -$31.4K |
|
32
Lockheed Martin
LMT
$106B
| $882K | 0.15% |
1,813
+7
| +0.4% | +$3.41K |
|
33
Home Depot
HD
$405B
| $845K | 0.14% |
2,674
+118
| +5% | +$37.3K |
|
34
Berkshire Hathaway Class B
BRK.B
$1.09T
| $841K | 0.14% |
2,722
+166
| +6% | +$51.3K |
|
35
Eli Lilly
LLY
$657B
| $833K | 0.14% |
2,276
-348
| -13% | -$127K |
|
36
Amazon
AMZN
$2.44T
| $808K | 0.14% |
9,622
-167
| -2% | -$14K |
|
37
Abbott
ABT
$231B
| $778K | 0.13% |
7,089
-1,065
| -13% | -$117K |
|
38
Thermo Fisher Scientific
TMO
$186B
| $752K | 0.13% |
1,365
+191
| +16% | +$105K |
|
39
Pfizer
PFE
$141B
| $751K | 0.13% |
14,660
+510
| +4% | +$26.1K |
|
40
Merck
MRK
$210B
| $738K | 0.13% |
6,613
+931
| +16% | +$104K |
|
41
Bank of America
BAC
$376B
| $670K | 0.11% |
20,240
+1,953
| +11% | +$64.7K |
|
42
Cigna
CI
$80.3B
| $635K | 0.11% |
1,916
+18
| +0.9% | +$5.96K |
|
43
JPMorgan Chase
JPM
$829B
| $593K | 0.1% |
4,424
+373
| +9% | +$50K |
|
44
Vanguard Russell 1000 ETF
VONE
$6.65B
| $583K | 0.1% |
3,344
-435
| -12% | -$75.8K |
|
45
Invesco FTSE RAFI US 1000 ETF
PRF
$8.08B
| $577K | 0.1% |
3,718
| – | – |
|
46
Procter & Gamble
PG
$368B
| $573K | 0.1% |
3,783
-78
| -2% | -$11.8K |
|
47
Accenture
ACN
$162B
| $557K | 0.09% |
2,086
-311
| -13% | -$83K |
|
48
iShares Currency Hedged MSCI EAFE ETF
HEFA
$6.52B
| $556K | 0.09% |
+20,604
| New | +$556K |
|
49
Vertex Pharmaceuticals
VRTX
$100B
| $554K | 0.09% |
1,917
+75
| +4% | +$21.7K |
|
50
Plains All American Pipeline
PAA
$12.7B
| $532K | 0.09% |
45,275
| – | – |
|